Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Burden of lymphoma in China, 1990−2019: an analysis of the global burden of diseases, injuries, and risk factors study 2019
Weiping Liu, Jiangmei Liu, Yuqin Song, et al.
Aging (2022) Vol. 14, Iss. 7, pp. 3175-3190
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Increasing incidence and prevalence of Hodgkin’s lymphoma in Finland: a population-based registry study
Tessa Antikainen, Noora Hannuksela, Anna Anttalainen, et al.
European Journal of Public Health (2025)
Open Access
Improving access to chimeric antigen receptor T-cells for refractory or relapsing diffuse large B cell lymphoma therapy in Asia
Ya Hwee Tan, Dok Hyun Yoon, Andrew Davies, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Aloe-Emodin Decreases the Hypoxia-Induced Radioresistance by Interacting with Hypoxiainducible Factor-1 α in SU-DHL-4 Cells
Lili Zhang, Xiaojie Wang, Yue Zhang, et al.
Pharmaceutical Chemistry Journal (2025)
Closed Access
Influence of Vitamin D and Its Analogues in Type-B Lymphomas
Valerio Basile, Alessandro Allegra, Herbert Marini, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 135-135
Open Access
Comparative global burden analysis of lymphoma subtypes: a statistical evaluation of severity across global regions
Yu Liang, Yingying Tang, Yuanyuan Wanyan, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Cost-effectiveness analysis of glofitamab versus rituximab for relapsed or refractory diffuse large B-cell lymphoma patients in China
Hanrui Zheng, Linke Zou, Ming Hu
International Journal of Clinical Pharmacy (2025)
Closed Access
Patients’ experience with chimeric antigen receptor T-cell therapy for DLBCL in China: a qualitative study
Yiwen Mao, Lihong Huang, Haitao Ruan, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 5
Open Access | Times Cited: 10
The global burden of lymphoma: estimates from the Global Burden of Disease 2019 study
Ziyuan Shen, Z. Tan, Ge Li, et al.
Public Health (2023) Vol. 226, pp. 199-206
Closed Access | Times Cited: 9
Transcriptional activation of SIRT5 by FOXA1 reprograms glycolysis to facilitate the malignant progression of diffuse large B-cell lymphoma
Ye Zhang, Peng Lu, Shenhe Jin, et al.
Cellular Signalling (2024) Vol. 123, pp. 111356-111356
Closed Access | Times Cited: 2
Age-period-cohort analysis of gender differential trends in incidence and mortality of non-Hodgkin lymphoma in China, 1990-2019
Yuanyuan Yao, Hui Liu, Fei Zhao, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 5
Steady Decline of HBV DNA Load under NAs in Lymphoma Patients and a Higher Level of qAnti-HBc Predict HBV Reactivation
Yiqi Liu, Reyizha Nuersulitan, Chi Zhang, et al.
Journal of Clinical Medicine (2023) Vol. 13, Iss. 1, pp. 23-23
Open Access | Times Cited: 4
Global spatiotemporal distributions of lymphoma from 1990 to 2019: A Joinpoint regression analysis based on the global burden of disease study 2019, and projections until 2044
Jia‐Cheng Liu
Dialogues in Health (2024) Vol. 4, pp. 100182-100182
Open Access | Times Cited: 1
A Systematic Review of the Psychological Experience of Patients with Lymphoma
美佳 李
Nursing Science (2024) Vol. 13, Iss. 07, pp. 873-883
Closed Access | Times Cited: 1
Efficacy and Mechanism of Core Traditional Chinese Medicines for Treating Malignant Lymphoma based on Efficacy Studies: A Study Supported by Network Pharmacology and Molecular Docking
Jiayue Jin, Simeng Ren, Baojin Han, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 33, pp. 2652-2666
Closed Access | Times Cited: 1
Value for Money of CAR-T Cell Therapy for Patients with Diffuse Large B-cell Lymphoma in China: Evidence from a Cost-Effectiveness Analysis
Weijia Wu, Yuping Zhou, Yannan Wang, et al.
Applied Health Economics and Health Policy (2023) Vol. 21, Iss. 5, pp. 773-783
Closed Access | Times Cited: 2
Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in China
Jiaxin Liu, Yunfei Hu, Linjun Zhao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
MiR-525-5p inhibits diffuse large B cell lymphoma progression via the Myd88/NF-κB signaling pathway
Xiuchen Guo, Jingbo Zhang, Jingya Zeng, et al.
PeerJ (2023) Vol. 11, pp. e16388-e16388
Open Access | Times Cited: 2
Effect of autologous hematopoietic stem cell transplantation for patients with peripheral T-cell lymphoma in China: A propensity score-matched analysis
Hongye Gao, Meng Wu, Shaoxuan Hu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Study on the mechanism of Euscaphic acid in the treatment of non-Hodgkin lymphoma based on network pharmacology and molecular docking
Guangru Li, Chunyuan Liang, Yan Liu, et al.
Research Square (Research Square) (2024)
Open Access
The trend of lymphoma incidence in China from 2005 to 2017 and lymphoma incidence trend prediction from 2018 to 2035: a log-linear regression and Bayesian age-period-cohort analysis
Kangqian Lin, Jianjiang Shao, Yuting Cao, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Racial disparities in the incidence and survival outcomes in diffuse large B‐cell lymphoma in adolescents and young adults
Mustafa Wasifuddin, Nosakhare Paul Ilerhunmwuwa, Henry Becerra, et al.
European Journal Of Haematology (2024) Vol. 113, Iss. 4, pp. 454-459
Closed Access
Surface temperature characteristics of patients with malignant lymphoma based on infrared thermal imaging technology
Junfan Wu, Qiuran Jia, Dongyun Li, et al.
Research Square (Research Square) (2024)
Closed Access
Secular trends in incidence and mortality of non-Hodgkin’s lymphoma in China, 1990–2019, and predictions to 2030: Outlook for the future burden of disease
Hongbo Su, Shuping Xie, Jun Lyu, et al.
Tumori Journal (2024) Vol. 110, Iss. 5, pp. 348-354
Closed Access
Contemporaneous symptom networks analysis in lymphoma patients during chemotherapy: protocol for a single-centre prospective cross-sectional study
Xingyu Chen, Li-Zhen Liu, Wenxin Li, et al.
BMJ Open (2024) Vol. 14, Iss. 8, pp. e082822-e082822
Open Access
Effect of infection with hepatitis B virus on the survival outcome of diffuse large B-cell lymphoma in the prophylactic antiviral era
Reyizha Nuersulitan, Miaomiao Li, Lan Mi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top